Some drugs are known as nephrotoxic, which means that their effects can cause damage to the kidneys. Drugs such as certain ...

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of ...

Apellis Pharmaceuticals APLS announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

The supplemental New Drug Application for the C3G and IC-MPGN indications is supported by data from the phase 3 VALIANT study.

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...

Our kidneys take on the weighty need of filtrating virtually fifty gallons of blood on a daily basis. And, our eating habits do impose unperceived stress on these vital organs. Nowadays, the ...

A new study published in the Journal of American Medical Association showed that when taken with glucocorticoids for ...

CKD is responsible for chronic inflammation and oxidative stress and results in the build-up of uremic toxins, which ...

CHMP recommends approval for Averoa’s Xoanacyl, an oral therapy for chronic kidney disease: Grenoble, France Friday, April 4, 2025, 12:00 Hrs [IST] Averoa, a biopharmaceutical c ...